The US Congress expands requirements for pharmaceutical companies to file agreements with the FTC and DOJ

Krista Carver,Andrew D. Lazerow,Michael Stern,Kavita Pillai

The US Congress expands requirements for pharmaceutical companies to file agreements with the FTC and DOJ

2018

Krista Carver
Andrew D. Lazerow
Michael Stern
Kavita Pillai

What occurred and why does it matter? President Trump on October 24 signed the SUPPORT for Patients and Communities Act (H.R. 6), which together with the Patient Right to Know Drug Prices Act…

Keywords:

Business
Drug prices
International trade
competition policy
Right to know

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations